Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gold Nanoparticles Kill Cancer Cells by Stopping Cell Division

By LabMedica International staff writers
Posted on 03 Mar 2010
Gold nanoparticles that penetrate the nucleus of cancer cells damage the DNA, prevent the cells from completing the process of cell division, and lead to programmed death (apoptosis) of the cells. More...


Investigators from the Georgia Institute of Technology (Atlanta, USA; www.gatech.edu) had previously shown that gold nanoparticles could be introduced into cancer cells, and after having been stimulated by laser light destroy them. In the current study, they have developed a solution for treating cancer cells that could not be reached by laser light.

The researchers reported in the February 19, 2010, online edition of the Journal of the American Chemical Society (JACS) that by labeling the gold nanoparticles with the appropriate peptides, they could be directed to first the cytoplasm and then the nucleus of cancer cells. The cancer cells, which had been isolated from ear, nose, and throat cancers, were growing in tissue culture.

"Previously, we have shown that we can bring gold nanoparticles into cancer cells and by shining a light on them, can kill the cells. Now we have shown that if we direct those gold nanoparticles into the nucleus, we can kill the cancer cells that are in spots we cannot hit with the light,” explained senior author Dr. Mostafa El-Sayed, professor of chemistry at the Georgia Institute of Technology. "We have developed a system that can kill cancer cells by shining light on gold nanoparticles, but what if the cancer is in a place where we cannot shine light on it? To fix that problem, we have decorated the gold with a chemical that brings it inside the nucleus of the cancer cell and stops it from dividing. The gold works by interfering with the cells' DNA. The cell starts dividing and then it collapses. Once you have a cell with two nuclei, it dies.”

Related Links:

Georgia Institute of Technology




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.